En esta página
01RLYB precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
RLYB Rallybio Corporation - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ 10-K/10-Q Ago 6, 2026
$16,64
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$3,67mínimo 52 semanas
$17,57máximo 52 semanas
Capitalización Bursátil (MRQ)
$88M
P/E (TTM)
3.4
BPA (TTM)
$4.91
Ingresos (TTM)
$646.0K
tus insignias
Rango 52S
$4–$18
Calificación del Analista
HOLD
Precio Objetivo
·
P/E
3.4
ROE
64.9%
Margen de Beneficio Neto
7051.2%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
RLYB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$16.64
Capitalización Bursátil (MRQ)
$88M
P/E (TTM)
3.4
BPA (TTM)
$4.91
Ingresos (TTM)
$646.0K
ROE (TTM)
64.9%
Rango 52S
$4–$18
RLYB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 6 de febrero de 2026 | 1-for-8 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$858.0K2024-12-31 → 2025-12-31
BPA$-1.592021-12-31 → 2025-12-31
Flujo de caja libre·2021-12-31 → 2024-12-31
Margen neto7051.2%2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | RLYB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 3.4promedio 5A ≈-2.0 | ≈-2.0 | · | · | |
| P/S (TTM) | 136.7 | · | 115.3 | Sobrevalorado | |
| P/C (MRQ) | 0.9promedio 5A ≈1.0 | ≈1.0 | 2.4 | Infravalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | -2.9promedio 5A ≈-2.7 | ≈-2.7 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.5promedio 5A ≈1.0 | ≈1.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | RLYB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -4291.5% | · | -4045.6% | En línea | |
| EBITDA Margin (Margen EBITDA) | -3853.6% | · | -4045.6% | En línea | |
| Margen antes de impuestos (TTM) | 7120.9% | · | -3904.7% | En línea | |
| Margen de Beneficio Neto (TTM) | 7051.2% | · | -3907.0% | En línea | |
| ROA (TTM) | 61.1%promedio 5A ≈-38.6% | ≈-38.6% | -62.1% | De primer nivel | |
| ROE (TTM) | 64.9%promedio 5A ≈-47.9% | ≈-47.9% | -71.0% | De primer nivel | |
| ROIC | -57.0%promedio 5A ≈-59.1% | ≈-59.1% | -75.7% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | RLYB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 27.3promedio 5A ≈16.4 | ≈16.4 | 3.5 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 13.0promedio 5A ≈15.6 | ≈15.6 | 3.2 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | RLYB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 34.9% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | RLYB | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0 | · | 0.0 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$122.6K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
12.9%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 31 de marzo de 2026 | May 12, 2026 | $-1.46 | $-1.22 | -20.1% |
| 31 de diciembre de 2025 | $-1.03 | $-1.20 | 13.9% | |
| 30 de septiembre de 2025 | $-1.12 | $-1.75 | 36.0% | |
| 30 de junio de 2025 | $-1.76 | $-2.00 | 12.0% | |
| 31 de marzo de 2025 | $-1.68 | $-2.12 | 20.8% | |
| 31 de diciembre de 2024 | $-2.00 | $-2.34 | 14.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $858.0K | $636.0K | |
| R&D Expense | $20M | $42M | |
| SG&A Expense | $14M | $20M | |
| Operating Expenses | $34M | $61M | |
| Operating Income | $-33M | $-60M | |
| Other Non-op | $23M | $744.0K | |
| Pretax Income | $-9M | $-56M | |
| Income Tax | $0 | $0 | |
| Net Income | $-9M | $-58M | |
| EPS (Basic) | $-1.59 | $-10.61 | |
| EPS (Diluted) | $-1.59 | $-10.61 | |
| Shares (Basic) | 5,629,370 | 5,443,332 | |
| Shares (Diluted) | 5,629,370 | 5,443,332 | |
| EBITDA | $-33M | $-60M |
Balance general
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $31M | $14M | |
| Short-term Investments | $23M | $52M | |
| Prepaid Expense | $7M | $2M | |
| Other Current Assets | $3M | $995.0K | |
| Current Assets | $61M | $68M | |
| PP&E (Net) | $23.0K | $115.0K | |
| PP&E (Gross) | $503.0K | $769.0K | |
| Accum. Depreciation | $480.0K | $654.0K | |
| Other Non-current Assets | $810.0K | $0 | |
| Total Assets | $62M | $68M | |
| Accounts Payable | $126.0K | $278.0K | |
| Accrued Liabilities | $4M | $5M | |
| Current Liabilities | $4M | $6M | |
| Capital Leases | $82.0K | $0 | |
| Total Liabilities | $4M | $6M | |
| Common Stock | $4.0K | $4.0K | |
| Paid-in Capital | $360M | $355M | |
| Retained Earnings | $-302M | $-293M | |
| AOCI | $18.0K | $68.0K | |
| Stockholders' Equity | $58M | $62M | |
| Liabilities + Equity | $62M | $68M | |
| Shares Outstanding | 5,283,321 | 5,188,743 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $92.0K | $131.0K | |
| Stock-based Comp | $5M | $8M | |
| Operating Cash Flow | $-30M | $-49M | |
| CapEx | · | $0 | |
| Investing Cash Flow | $47M | $33M | |
| Stock Issued | $0 | $5M | |
| Net Stock Activity | $0 | $5M | |
| Financing Cash Flow | $16.0K | $5M | |
| Net Change in Cash | $17M | $-11M | |
| Free Cash Flow | · | $-49M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -3853.6% | -10082.7% | |
| Net Margin | -1046.4% | -9629.2% | |
| Pretax Margin | -1046.4% | -9256.0% | |
| EBITDA Margin | -3853.6% | -10082.7% | |
| ROA | -13.8% | -62.9% | |
| ROE | -17.3% | -87.2% | |
| ROIC | -57.0% | -98.1% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.5 | 10.9 | |
| Quick Ratio | 13.0 | 10.5 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $10.97 | $1.49 | |
| Revenue / Share | $0.15 | $0.01 | |
| Cash Flow / Share | $-5.30 | $-1.13 | |
| Cash / Share | $5.94 | $0.33 | |
| EPS (TTM) | $-1.59 | $-10.61 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 34.9% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $858.0K | $636.0K | |
| Net Income TTM | $-9M | $-58M | |
| Market Cap | $4M | $40M | |
| P/E | -0.4 | -0.1 | |
| P/S | 4.2 | 62.7 | |
| P/B | 0.1 | 0.6 | |
| P / Tangible Book | 0.1 | 0.6 | |
| P / Cash Flow | -0.1 | -0.8 | |
| P / FCF | · | -0.8 | |
| Earnings Yield | -231.8% | -1105.2% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $212.0K | $222.0K | $212.0K | $212.0K | $212.0K | $38.0K | $299.0K | $299.0K | $0 | · | $0 | $0 | |
| R&D Expense | $758.0K | $3M | $4M | $4M | $6M | $6M | $7M | $8M | $13M | $13M | $16M | $13M | $13M | |
| SG&A Expense | $5M | $6M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $7M | $5M | $6M | $7M | |
| Operating Expenses | $6M | $9M | $7M | $7M | $10M | $10M | $12M | $12M | $17M | $20M | $21M | $19M | $20M | |
| Operating Income | $-6M | $-9M | $-6M | $-7M | $-10M | $-10M | $-12M | $-12M | $-17M | $-20M | $-21M | $-19M | $-20M | |
| Other Non-op | $424.0K | $254.0K | $0 | $22M | $118.0K | $174.0K | $183.0K | $251.0K | $143.0K | $167.0K | $35.0K | $92.0K | $62.0K | |
| Pretax Income | $45M | $-8M | $-7M | $16M | $-9M | $-9M | · | $-11M | $-16M | $-18M | $-20M | $-18M | $-18M | |
| Income Tax | $1M | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $44M | $-8M | $-6M | $16M | $-10M | $-9M | $-11M | $-11M | $-16M | $-19M | $-20M | $-18M | $-19M | |
| EPS (Basic) | $7.66 | $-1.46 | $-1.52 | $0.36 | $-1.73 | $-1.69 | $-9.51 | $-0.26 | $-0.37 | $-0.47 | $-0.50 | $-0.45 | $-0.46 | |
| EPS (Diluted) | $7.53 | $-1.46 | $-1.52 | $0.36 | · | $-1.69 | $-9.51 | $-0.26 | $-0.37 | $-0.47 | $-0.50 | $-0.45 | $-0.46 | |
| Shares (Basic) | 5,699,111 | 5,688,584 | · | 45,058,591 | 5,605,116 | 5,597,528 | · | 44,593,221 | 44,128,059 | 40,773,615 | · | 40,531,497 | 40,363,902 | |
| Shares (Diluted) | 5,797,913 | 5,688,584 | · | 45,058,591 | · | 5,597,528 | · | 44,593,221 | 44,128,059 | 40,773,615 | · | 40,531,497 | 40,363,902 | |
| EBITDA | $-6M | $-9M | · | $-7M | $-10M | $-10M | · | $-12M | $-17M | $-20M | · | $-19M | $-20M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $41M | $31M | $32M | $9M | $15M | $14M | $25M | $17M | $19M | $24M | $19M | $33M | |
| Short-term Investments | $0 | $5M | $23M | $27M | $36M | $40M | $52M | $50M | $72M | $75M | $85M | $102M | $105M | |
| Prepaid Expense | $4M | $7M | $7M | $7M | $5M | $3M | $2M | $3M | $3M | $4M | $5M | $11M | $9M | |
| Other Current Assets | $4M | $6M | $3M | $3M | $573.0K | $872.0K | $995.0K | $2M | $1M | $768.0K | $2M | $4M | $1M | |
| Current Assets | $97M | $53M | $61M | $67M | $50M | $57M | $68M | $78M | $91M | $99M | $115M | $132M | $147M | |
| PP&E (Net) | $0 | $20.0K | $23.0K | $26.0K | $61.0K | $87.0K | $115.0K | $145.0K | $177.0K | $211.0K | $246.0K | $282.0K | $308.0K | |
| PP&E (Gross) | · | · | $503.0K | · | · | · | $769.0K | · | · | · | $769.0K | · | · | |
| Accum. Depreciation | · | · | $480.0K | · | · | · | $654.0K | · | · | · | $523.0K | · | · | |
| Other Non-current Assets | $810.0K | $810.0K | $810.0K | $810.0K | · | · | $0 | · | · | · | · | · | · | |
| Total Assets | $98M | $54M | $62M | $68M | $51M | $58M | $68M | $79M | $92M | $99M | $116M | $133M | $148M | |
| Accounts Payable | $833.0K | $940.0K | $126.0K | $269.0K | $119.0K | $400.0K | $278.0K | $583.0K | $1M | $470.0K | $976.0K | $464.0K | $689.0K | |
| Accrued Liabilities | $1M | $3M | $4M | $4M | $4M | $3M | $5M | $6M | $10M | $9M | $8M | $9M | $7M | |
| Current Liabilities | $4M | $4M | $4M | $5M | $5M | $4M | $6M | $8M | $12M | $10M | $9M | $9M | $8M | |
| Capital Leases | $0 | $55.0K | $82.0K | $108.0K | · | · | $0 | $0 | $58.0K | $116.0K | $173.0K | $211.0K | $266.0K | |
| Total Liabilities | $4M | $4M | $4M | $5M | $5M | $4M | $6M | $8M | $12M | $10M | $9M | $10M | $8M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $361M | $361M | $360M | $359M | $358M | $356M | $355M | $353M | $351M | $343M | $341M | $339M | $336M | |
| Retained Earnings | $-267M | $-310M | $-302M | $-296M | $-312M | $-302M | $-293M | $-282M | $-271M | $-254M | $-235M | $-215M | $-197M | |
| AOCI | $0 | $1.0K | $18.0K | $24.0K | $17.0K | $47.0K | $68.0K | $169.0K | $-71.0K | $-71.0K | $15.0K | $-208.0K | $-272.0K | |
| Stockholders' Equity | $94M | $50M | $58M | $63M | $46M | $54M | $62M | $71M | $80M | $89M | $106M | $124M | $139M | |
| Liabilities + Equity | $98M | $54M | $62M | $68M | $51M | $58M | $68M | $79M | $92M | $99M | $116M | $133M | $148M | |
| Shares Outstanding | 5,306,894 | 5,290,236 | 5,283,321 | 41,935,841 | 41,707,153 | 41,612,039 | 5,188,743 | 41,487,586 | 41,487,586 | 37,811,970 | 37,829,565 | 37,800,856 | 37,790,856 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.0K | $3.0K | $3.0K | $35.0K | $26.0K | $28.0K | $30.0K | $32.0K | $34.0K | $35.0K | $36.0K | $37.0K | $38.0K | |
| Stock-based Comp | $424.0K | $613.0K | $774.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Operating Cash Flow | $46M | $-8M | $-5M | $-7M | $-8M | $-10M | $-10M | $-14M | $-10M | $-15M | $-12M | $-16M | $-13M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $12.0K | $0 | $0 | |
| Investing Cash Flow | $6M | $18M | $4M | $29M | $3M | $11M | $-2M | $22M | $3M | $10M | $17M | $3M | $6M | |
| Stock Issued | · | $3.0K | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $-209.0K | · | |
| Net Stock Activity | · | $3.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $131.0K | $3.0K | $6.0K | $0 | $10.0K | $0 | $18.0K | $-11.0K | $5M | $0 | $72.0K | $0 | $210.0K | |
| Net Change in Cash | $52M | $10M | $-748.0K | $23M | $-5M | $876.0K | $-11M | $9M | $-3M | $-5M | $5M | $-13M | $-7M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -4119.3% | · | -3266.5% | -4743.9% | -4561.3% | · | -4035.5% | -5697.3% | · | · | · | · | |
| Net Margin | · | -3904.7% | · | 7554.7% | -4576.9% | -4452.4% | · | -3834.8% | -5430.1% | · | · | · | · | |
| Pretax Margin | · | -3904.7% | · | 7554.7% | -4441.5% | -4175.5% | · | -3621.7% | -5267.2% | · | · | · | · | |
| EBITDA Margin | · | -4119.3% | · | -3266.5% | -4743.9% | -4561.3% | · | -4035.5% | -5697.3% | · | · | · | · | |
| ROA | 58.6% | -14.7% | · | 21.8% | -13.5% | -12.0% | · | -10.8% | -13.5% | -14.5% | · | -13.3% | -12.3% | |
| ROE | 62.2% | -15.9% | · | 23.9% | -15.4% | -13.2% | · | -11.8% | -14.8% | -15.6% | · | -14.4% | -13.0% | |
| ROIC | -5.8% | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 27.3 | 12.9 | · | 14.7 | 10.0 | 14.7 | · | 9.6 | 7.5 | 9.8 | · | 14.1 | 18.2 | |
| Quick Ratio | 26.0 | 11.3 | · | 13.1 | 9.1 | 13.9 | · | 9.2 | 7.3 | 9.3 | · | 12.9 | 17.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.81 | $9.50 | · | $1.50 | $1.10 | $1.30 | · | $1.71 | $1.93 | $2.36 | · | $3.27 | $3.68 | |
| Revenue / Share | $0.00 | $0.04 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $0.01 | · | · | · | · | |
| Cash Flow / Share | · | $-1.40 | · | · | · | $-0.23 | · | · | · | $-0.38 | · | · | · | |
| Cash / Share | $17.50 | $7.81 | · | $0.77 | $0.23 | $0.36 | · | $0.61 | $0.40 | $0.51 | · | $0.51 | $0.86 | |
| EPS (TTM) | $4.91 | · | · | · | $-11.83 | $-11.83 | · | $-1.60 | $-1.79 | $-1.88 | · | $-1.78 | $-1.93 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $646.0K | $858.0K | · | $674.0K | $761.0K | $848.0K | · | · | · | · | · | · | · | |
| Net Income TTM | $46M | $-8M | · | $-14M | $-42M | $-48M | · | $-67M | $-74M | $-76M | · | $-71M | $-71M | |
| Market Cap | $85M | $47M | · | $21M | $14M | $27M | · | $49M | $56M | $70M | · | $127M | $214M | |
| P/E | 3.3 | · | · | · | -0.2 | -0.4 | · | -5.8 | -6.0 | -7.9 | · | -15.1 | -23.5 | |
| P/S | 131.4 | 55.3 | · | 248.4 | 148.2 | 257.1 | · | · | · | · | · | · | · | |
| P/B | 0.9 | 0.9 | · | 0.3 | 0.3 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 1.0 | 1.5 | |
| P / Tangible Book | 0.9 | 0.9 | · | 0.3 | 0.3 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 1.0 | 1.5 | |
| P / Cash Flow | · | -5.9 | · | · | · | -2.7 | · | · | · | -4.5 | · | · | · | |
| Earnings Yield | 30.7% | · | · | · | -437.5% | -225.8% | · | -17.1% | -16.7% | -12.7% | · | -6.6% | -4.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $858.0K | $636.0K | · | · | · |
| Margen Operativo % | -3853.6% | -10082.7% | · | · | · |
| Beneficio neto | $-9M | $-58M | $-75M | $-67M | $-47M |
| EPS Diluido | $-1.59 | $-10.61 | $-1.84 | $-2.09 | $-1.84 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 14.5 | 10.9 | 12.4 | 16.7 | 27.6 |
| Ratio Rápido | 13.0 | 10.5 | 11.9 | 15.7 | 26.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-49M | $-60M | $-57M | $-46M |
Propietarios institucionales (13F) 41 declarantes · $67.8M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
41
Valor en tenencia
$67.8M
Nuevas posiciones
9
Posiciones cerradas
9
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 9 | 9 | 9 | 7 | · |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado. Cambio vs trimestre anterior no mostrado: la cobertura de los presentadores difiere demasiado entre estos dos trimestres para una comparación fiable.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | $14 821 632 | 926 352 | 21,85% | Acciones |
| FMR LLC | $12 715 520 | 794 720 | 18,75% | Acciones |
| VIKING GLOBAL INVESTORS LP | $8 389 552 | 524 347 | 12,37% | Acciones |
| TPG GP A, LLC | $6 056 816 | 378 551 | 8,93% | Acciones |
| Pivotal bioVenture Partners Investment Advisor LLC | $4 809 264 | 300 579 | 7,09% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $3 198 512 | 199 907 | 4,72% | Acciones |
| Nantahala Capital Management, LLC | $3 014 752 | 188 422 | 4,44% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 759 952 | 172 497 | 4,07% | Acciones |
| Almitas Capital LLC | $1 930 912 | 120 682 | 2,85% | Acciones |
| Rangeley Capital, LLC | $1 677 600 | 104 850 | 2,47% | Acciones |
| New Leaf Venture Partners, L.L.C. | $1 647 500 | 3 301 603 | 2,43% | Acciones |
| CITADEL ADVISORS LLC | $1 155 200 | 72 200 | 1,70% | Acciones |
| AJU IB Investment Co., Ltd. | $846 176 | 94 334 | 1,25% | Acciones |
| Mariner, LLC | $809 056 | 50 566 | 1,19% | Acciones |
| JANE STREET GROUP, LLC | $758 768 | 47 423 | 1,12% | Acciones |
| VANGUARD GROUP INC | $697 147 | 1 016 249 | 1,03% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $512 865 | 32 047 | 0,76% | Acciones |
| BlackRock, Inc. | $485 312 | 30 332 | 0,72% | Acciones |
| XTX Topco Ltd | $343 952 | 21 497 | 0,51% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $269 120 | 16 820 | 0,40% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $265 904 | 16 619 | 0,39% | Acciones |
| STATE STREET CORP | $207 936 | 12 996 | 0,31% | Acciones |
| Quadrature Capital Ltd | $207 920 | 12 995 | 0,31% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $180 480 | 11 280 | 0,27% | Acciones |
| Vanguard Global Advisers, LLC | $23 072 | 1 442 | 0,03% | Acciones |
| Hartford Financial Management Inc. | $13 967 | 812 | 0,02% | Acciones |
| TWO SIGMA ADVISERS, LP | $13 242 | 19 300 | 0,02% | Acciones |
| Caitong International Asset Management Co., Ltd | $6 944 | 434 | 0,01% | Acciones |
| UBS Group AG | $2 336 | 146 | 0,00% | Acciones |
| Truvestments Capital LLC | $2 064 | 129 | 0,00% | Acciones |
| MORGAN STANLEY | $2 000 | 125 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 920 | 120 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $1 324 | 77 | 0,00% | Acciones |
| Fortitude Family Office, LLC | $912 | 53 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $592 | 37 | 0,00% | Acciones |
| EverSource Wealth Advisors, LLC | $496 | 31 | 0,00% | Acciones |
| HRT FINANCIAL LP | $410 | 25 657 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $145 | 9 | 0,00% | Acciones |
| Allworth Financial LP | $96 | 6 | 0,00% | Acciones |
| BARCLAYS PLC | $48 | 3 | 0,00% | Acciones |
| DANSKE BANK A/S | $16 | 1 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar, Scott M. Rocklage ×2 presentaciones | 6 de mayo de 2026 | 0,00% | Enmienda | · | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried ×2 presentaciones | 3 de marzo de 2026 | 7,20% | Enmienda | M&A / venta | SEC |
| Nan Fung Group Holdings Limited, NF Investment Holdings Limited, Pivotal bioVenture Partners Fund I, L.P., Pivotal bioVenture Partners Fund I G.P., L.P., Pivotal bioVenture Partners Fund I U.G.P. Ltd., Pivotal Partners Ltd, Pivotal Life Sciences Holdings Limited, Nan Fung Life Sciences Holdings Limited ×2 presentaciones | 12 de febrero de 2024 | · | Presentación inicial | · | SEC |
| 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Dr. Kush Parmar, Dr. Scott M. Rocklage ×2 presentaciones | 7 de junio de 2022 | · | Presentación inicial | · | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter | 12 de agosto de 2021 | · | Presentación inicial | Estructura de capital | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 15 insiders · 4 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Stephen Uden | Chief Executive Officer | 6 de octubre de 2026 M | 115 620 | 0 | 0 | $0 |
| Jonathan I Lieber | Chief Financial Officer | 9 de octubre de 2026 M | 13 650 | 0 | 1 | $-3 992 |
| Jeffrey M Fryer | Chief Financial Officer & Treasurer | 21 de marzo de 2022 P | 47 048 | 0 | 0 | $0 |
| Steven Ryder | Chief Medical Officer | 14 de febrero de 2025 A | · | 0 | 0 | $0 |
| Paula Soteropoulos | Consejero | 16 de octubre de 2026 M | 6 544 | 0 | 0 | $0 |
| Helen M Boudreau | Consejero | 16 de octubre de 2026 M | 8 604 | 0 | 0 | $0 |
| Robert Lorne Hopfner | Consejero | 12 de octubre de 2026 M | 14 820 | 0 | 0 | $0 |
| Hui Liu | Consejero | 24 de septiembre de 2026 M | 12 044 | 0 | 0 | $0 |
| Wendy Chung | Consejero | 16 de septiembre de 2026 M | 3 562 | 0 | 0 | $0 |
| Martin Mackay | Consejero | 18 de febrero de 2026 A | 282 609 | 0 | 0 | $0 |
| Ronald Hunt | Consejero | 18 de febrero de 2026 A | 2 301 603 | 0 | 0 | $0 |
| Christine A Nash | Consejero | 13 de mayo de 2025 A | · | 0 | 0 | $0 |
| Kush Parmar | Consejero | 15 de mayo de 2024 A | 2 378 969 | 0 | 0 | $0 |
| Timothy M Shannon | Consejero | 3 de enero de 2022 A | 2 409 712 | 0 | 0 | $0 |
| FMR LLC | · | 2 de agosto de 2021 C | 1 694 388 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 5 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 11 754 SH | 10 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 6 675 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 32 447 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 134 620 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 578 NS | 31 de julio de 2026 | N-PORT |
RLYB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 6 analistas
VENTA
0 0,0%
Compra fuerte
0 0,0%
Compra
3 50,0%
Mantener
1 16,7%
Venta
2 33,3%
Venta fuerte
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| CNXU | · | · | · | · | · | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| GRML | · | · | · | · | -104.9% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026